SCH58261 restored the decrease in GLT-1 level and subsequently decreased the glutamate level, which indicated that SCH58261 alleviates cognitive impairment in CP mice by relieving excitatory neurotoxicity. Here, SLC1A2 is linked to Cognitive impairment.